Kindred Biosciences (KIN) Tops Q4 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Kindred Biosciences (KIN) Tops Q4 EPS by 9c

Kindred Healthcare (KND) Reports KIND-012 Met Primary Endpoint in Pilot Field Study of Pyrexia in Horses

March 16, 2015 4:04 PM EDT

Kindred Biosciences (NASDAQ: KIN) announced positive results from its pilot field study of KIND-012 for the control of pyrexia (fever) in horses.

This study, which is the equivalent of a Phase 2 study, was a randomized, blinded, placebo-controlled, crossover study that enrolled 31 adult horses. The... More